Publications

Evaluation of the Antibody in Lymphocyte Supernatant Assay to Detect Active Tuberculosis

Margaretha Sariko, Caitlin Anderson, Buliga S. Mujaga, Jean Gratz, Stellah G. Mpagama, Scott Heysell, Gibson Kibiki, Blandina Mmbaga, Eric Houpt, Tania Thomas

2017

Evaluation of XpertMTB/Rif performance for diagnosis of tuberculosis among HIV positive patients in northern Tanzania

Edson W. Mollel, Jaffu O. Chilongola, Stellah G. Mpagama, Gibson S. Kibiki

2017

Gridlock from Diagnosis to Treatment of Multidrug-Resistant Tuberculosis (MDR-TB) in Tanzania: Illuminating Potential Factors for Possible Intervention

Alphonce A Liyoyo, Scott K Heysell, Riziki M Kisonga, Johnson J Lyimo, Liberate J Mleoh, Beatrice K Mutayoba, Isaack A...

2017

High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial

Martin J Boeree,PhD, Norbert Heinrich,MD, Rob Aarnoutse, PhD, Andreas Diacon, PhD, Rodney Dawson, PhD, Sunita Rehal, MSc, Prof Gibson S Kibiki,...

2017

Introducing the ESAT-6 free IGRA, a companion diagnostic for TB vaccines based on ESAT-6

Morten Ruhwald, Lena de Thurah, Davis Kuchaka, Mostafa Rafaat Zaher, Ahmed M. Salman, Abdel-Rahman Abdel-Ghaffar, Faten Aly Shoukry, Sascha Wilk Michelsen, Bolette Soborg, Thomas Blauenfeldt,...

2017

Linking rifampicin exposure to treatment response over six months in patients with pulmonary tuberculosis

Elin M Svensson, Robin J Svensson, Lindsey te Brake, Martin Boeree, Norbert Heinrich, Gavin Churchyard, Rodney Dawson, Andreas H Diacon, Gibson S Kibiki, Lilian T...

2017

Pharmacokinetics, tolerability and bacteriological response of 600, 900 and 1200 mg rifampicin daily in patients with pulmonary TB

R. E. Aarnoutse, G. S. Kibiki, K Reither, H. H. Semvua, F Haraka, C. M. Mtabho, S. G. Mpagama, J van den Boogaard, I. M. Sumari-de Boer, C...

2017

Predictors for Mortality among Multidrug-Resistant Tuberculosis Patients in Tanzania

Edson W. Mollel and Jaffu O. Chilongola

2017